Carriers of the PNPLA3 rs738409 GG genotype had a 3.81-fold higher risk of developing MASLD compared with the combined GC/CC genotype group (P_FDR<0.001);. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.